Media no image

Partnership named Best Long Term Care Provider at the Health Insurance Awards for fourth year

Press Releases   •   Nov 07, 2012 12:38 GMT

Partnership named Best Long Term Care Provider at the Health Insurance Awards for fourth year

Partnership has been recognised as the Best Long Term Care Provider at the 2012 Health Insurance Awards for the fourth year in a row.

The awards, voted by intermediaries, are the premier awards for the UK health insurance and protection industry and recognise excellence in both the intermediary and provider communities.

Commenting on the award, Chris Horlick, Managing Director of Care at Partnership said “I am delighted that Partnership has been awarded this prestigious accolade for a fourth year in a row. Partnership has campaigned tirelessly throughout 2012 to raise awareness of the need for self-funders to access specialist care fees advice with the Government, Parliament and other key stakeholders including local authorities, care providers and consumers.

I am delighted that our campaigning and the hard work of Partnership’s people in providing a first class service to intermediaries has been recognised with this award.

Cinven is a leading European private equity firm, founded in 1977, with offices in Guernsey, London, Frankfurt, Paris, Milan, Luxembourg and Hong Kong. We acquire European-based companies that require an equity investment by our funds of €100 million or more. While Europe remains our focus, Cinven’s Portfolio team helps our European portfolio companies take advantage of international best practices and growth in global markets, in particular opportunities in emerging economies, including those of Asia. We focus on six sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials, and Technology, Media and Telecommunications (TMT).

Partnership named Best Long Term Care Provider at the Health Insurance Awards for fourth year Partnership has been recognised as the Best Long Term Care Provider at the 2012 Health Insurance Awards for the fourth year in a row. The awards, voted by intermediaries, are the premier awards for the UK health insurance and protection industry and recognise excellence in both the intermediary...

Read more »
Media no image

Cinven completes acquisition of Amdipharm

News   •   Oct 25, 2012 12:44 BST

European private equity firm, Cinven, today announces completion of its acquisition of Amdipharm, the family-owned international niche pharmaceuticals business, for a total consideration of £367 million.  This follows Cinven’s acquisition of Mercury Pharma, an international specialty pharmaceuticals company, in August 2012.

Amdipharm will be merged, over time, with Cinven’s existing portfolio company, Mercury Pharma. The combined group has an enterprise value in excess of £830 million, with revenues approaching £250 million and a portfolio of more than 200 drugs.

Cinven originated these investments through its healthcare sector focus. Its strategy is to grow a global niche pharmaceuticals business, both organically and through further acquisition opportunities, including in emerging markets, and to build on the existing scale of the combined business.

European private equity firm, Cinven, today announces completion of its acquisition of Amdipharm, the family-owned international niche pharmaceuticals business, for a total consideration of £367 million. This follows Cinven’s acquisition of Mercury Pharma, an international specialty pharmaceuticals company, in August 2012. Amdipharm will be merged, over time, with Cinven’s existing portfolio..

Read more »
Media no image

Cinven and Warburg Pincus announce the exercise of the over-allotment option in connection with the placement of 37 million shares of Ziggo N.V. announced on 24 October 2012

Press Releases   •   Oct 24, 2012 12:38 BST

Cinven Cable Investments S.à r.l., WP Holdings IV B.V. (respectively “Cinven” and “Warburg Pincus”) and their co-investors announce that, in relation to the placement of 37 million shares of Ziggo N.V. (“Ziggo”) announced on 24 October 2012, the Joint Bookrunners have exercised their over-allotment option, resulting in the purchase of 3 million additional ordinary shares of Ziggo at a price of €24.75 per share.

Following the exercise and settlement of this over-allotment option, Cinven, Warburg Pincus and their co-investors will own a combined 74.2 million shares in Ziggo, representing approximately 37.1% of the capital.  Settlement of this over-allotment option is expected to occur on Friday 2 November 2012.

J.P. Morgan Securities plc and Morgan Stanley & Co. International plc are acting as Joint Global Coordinators and Joint Bookrunners. Deutsche Bank AG London Branch, UBS Limited, ABN Amro Bank N.V and Nomura International plc are acting as Joint Bookrunners for the Offering.

This document and the information contained herein is not for release, publication or distribution in whole or in part in or into the United States. These materials do not contain or constitute an offer for sale or the solicitation of an offer to purchase securities in the United States. The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended, (the “Securities Act”) and may not be offered or sold in the United States absent registration under the Securities Act or pursuant to an available exemption from, or a transaction not subject to, the registration requirements of the Securities Act.

This document is only addressed to and directed at persons in member states of the European Economic Area who are “qualified investors” within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC) (“Qualified Investors”). In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, Qualified Investors who are persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”) or who are high net worth entities falling within Article 49(2)(a) to (d) of the Order, and other persons to whom they may otherwise lawfully be communicated (all such persons together being referred to as “relevant persons”). Any investment activity to which this document relates is available only to relevant persons in the United Kingdom and Qualified Investors in any member state of the European Economic Area other than the United Kingdom, and will only be engaged with such persons.

Each of the Joint Bookrunners acted for Cinven, Warburg Pincus and certain of their co-investors in connection with the Offering and will not be responsible to anyone other than Cinven, Warburg Pincus and certain of their co-investors for providing the protections offered to its clients nor for providing advice in relation to the Offering.

In connection with the Offering, Morgan Stanley & Co. International plc (the "Stabilising Manager") (or persons acting on behalf of the Stabilising Manager) may over-allot shares or effect transactions with a view to supporting the market price of the shares at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager (or persons acting on behalf of the Stabilising Manager) will undertake stabilisation action. Any stabilisation action may begin on or after the date on which adequate public disclosure of the final price of the shares is made and, if begun, may be ended at any time, but it must end no later than 30 days after the date shares have been allotted in the Offering.

Each of the Joint Bookrunners may participate in the Offering on a proprietary basis.

Cinven is a leading European private equity firm, founded in 1977, with offices in Guernsey, London, Frankfurt, Paris, Milan, Luxembourg and Hong Kong. We acquire European-based companies that require an equity investment by our funds of €100 million or more. While Europe remains our focus, Cinven’s Portfolio team helps our European portfolio companies take advantage of international best practices and growth in global markets, in particular opportunities in emerging economies, including those of Asia. We focus on six sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials, and Technology, Media and Telecommunications (TMT).

Cinven Cable Investments S.à r.l., WP Holdings IV B.V. (respectively “Cinven” and “Warburg Pincus”) and their co-investors announce that, in relation to the placement of 37 million shares of Ziggo N.V. (“Ziggo”) announced on 24 October 2012, the Joint Bookrunners have exercised their over-allotment option, resulting in the purchase of 3 million additional ordinary shares of Ziggo at a price...

Read more »

Contacts 1 contact

  • Press Contact
  • Communications Director
  • yphzVadpnevrktyvssmnqua.Maydonlr@Cinqyluven.comylaikm
  • +44 (0)20 7661 3333

About Cinven

Cinven is a leading European private equity firm, founded in 1977. We acquire successful companies and help them grow and develop. We take a responsible approach towards our portfolio companies, their employees, suppliers and local communities, the environment and society.

Cinven is a leading European private equity firm, founded in 1977, with offices in Guernsey, London, Frankfurt, Paris, Milan, Luxembourg and Hong Kong. We acquire European-based companies that require an equity investment by our funds of €100 million or more. While Europe remains our focus, Cinven’s Portfolio team helps our European portfolio companies take advantage of international best practices and growth in global markets, in particular opportunities in emerging economies, including those of Asia. We focus on six sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials, and Technology, Media and Telecommunications (TMT).

Cinven acquires successful, high-quality companies and works with them to help them grow and develop, using our proven value creation strategies. Typically, Cinven holds its investments for between four to six years. We take a responsible approach towards our portfolio companies, their employees, suppliers and local communities, the environment and society.

Cinven has a strong and consistent investment track record. Since the firm was founded in 1977, we have completed transactions valued at in excess of €67 billion. We are responsible for many buyout industry 'firsts', including the first €1 billion - plus buyouts in France, the Netherlands, Spain and the UK. We are currently investing our fifth fund.

Cinven complies with the UK's Guidelines for Disclosure and Transparency in Private Equity published by the Walker Working Group in 2007, and with comparable codes throughout Europe. Cinven Partners LLP (‘Cinven’) is advisor to Cinven Limited and is authorised and regulated by the Financial Services Authority. Cinven Limited, the manager of the Cinven funds, is authorised and regulated by the Guernsey Financial Services Commission.